Gavi works to expand access to vaccines for children in some of the world’s poorest countries. Health experts say the move ...

Global health advocates are concerned that the U.S. is halting support for the the Gavi program that immunized roughly 1.1 ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...

The United States will stop sending money to Gavi, a global group that helps vaccinate children in low-income countries.

The Global Summit: Health & Prosperity through Immunisation sees a record number of donors pledge towards Gavi, the Vaccine ...

The European Commission has approved Johnson & Johnson's Ebola vaccine, developed by its Janssen pharmaceuticals unit and Bavarian Nordic. This is the first major regulatory approval of the ...

Researchers at Wageningen University & Research (WUR) are contributing to the development of a new vaccine designed to provide broad protection ...

HHS Secretary Robert F. Kennedy Jr. this week announced that the United States is pulling its funding for Gavi, the Vaccine ...

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific advisers crossed the line for her.

Kenya has been part of Gavi since 2001, strengthening its immunisation programme and expanding access to critical vaccines.

Two molecules found in various plants, including one extracted from birch, could prevent viruses as formidable as HIV, Ebola, ...

He envisions an end-to-end vaccine-manufacturing hub that will help to ensure vaccine sovereignty for Africa. “We want to own our destiny and not rely on others,” he says.